Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, Manon Carré, Bertrand Pourroy, Fanny Bouquet, Ariel Savina, Bruno Lacarelle, Joseph Ciccolini & Raphaelle Fanciullino. (2018) From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer. International Journal of Nanomedicine 13, pages 6677-6688.
Read now
Read now
Anyuan Zhong, Yufei Xing, Xue Pan, Minhua Shi & Huajun Xu. (2015) Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis. OncoTargets and Therapy 8, pages 3595-3601.
Read now
Read now
Edouard Alphandéry, Pierre Grand-Dewyse, Raphael Lefèvre, Chalani Mandawala & Mickael Durand-Dubief. (2015) Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects. Expert Review of Anticancer Therapy 15:10, pages 1233-1255.
Read now
Read now
Articles from other publishers (5)
Vahab Ziaei, Alireza Ghassempour, Fatemeh Davami, Bahareh Azarian, Mahdi Behdani, Hamed Dabiri & Mahdi Habibi-Anbouhi. (2023) Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1. Molecular and Cellular Biochemistry.
Crossref
Crossref
Hans H. Oberg, Christian Kellner, Daniel Gonnermann, Susanne Sebens, Dirk Bauerschlag, Martin Gramatzki, Dieter Kabelitz, Matthias Peipp & Daniela Wesch. (2018) Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells. Frontiers in Immunology 9.
Crossref
Crossref
Nelia Hernandez. (2017) Hepatotoxicity of New Antitumor Agents. Current Hepatology Reports 16:4, pages 293-297.
Crossref
Crossref
Tunyaboon Laemthong, Hannah H Kim, Kelly Dunlap, Caitlin Brocker, Dipak Barua, Daniel Forciniti, Yue-Wern Huang & Sutapa Barua. (2017) Bioresponsive polymer coated drug nanorods for breast cancer treatment. Nanotechnology 28:4, pages 045601.
Crossref
Crossref
Helen E. ColleyMunitta MuthanaSarah J. DansonLucinda V. JacksonMatthew L. BrettJoanne HarrisonSean F. CooleDaniel P. MasonLuke R. JenningsMelanie WongVamshi TulasiDennis NormanPeter M. LockeyLynne WilliamsAlexander G. DossetterEdward J. GriffenMark J. Thompson. (2015) An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer. Journal of Medicinal Chemistry 58:23, pages 9309-9333.
Crossref
Crossref